CMES partners for AI-based cancer screening platform
CMES partners with Cisen Biomaterials and Revosketch to develop an AI-based robotic platform for early cancer detection, combining their expertise in robotics, biomarkers, and diagnostics.
AI robotics-based cancer screening platform development
CMACE, Seegene, and Revosketch collaborate to develop an AI robotics-based ultra-precise cancer early screening platform, combining their expertise in automation, biomarkers, and molecular diagnostics.
Pulmuone and Revosketch collaborate on food safety diagnostics
Pulmuone and Revosketch signed an MOU to develop and commercialize CRISPR-Cas based food safety molecular diagnostic platform, aiming to enhance food safety diagnostics and lead the global market.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.